Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nawel Belmecheri"'
Autor:
Robin Noel, Christophe Zemmour, Catalina Montes de Oca, Nawel Belmecheri, Thérèse Aurran-Schleinitz, Diane Coso, Leonor Lopez Almeida, Lénaïg Mescam, Norbert Vey, Jean Sébastien Bladé, Borhane Slama, Reda Bouabdallah, Jean-Marc Schiano de Colella
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTRelapsed/Refractory Diffuse Large B Cell Lymphoma have a dismal prognosis in need of innovative treatments. This prospective phase 2 study enrolled 32 patients between 2013 and 2017 with Relapsed/Refractory Diffuse Large B Cell Lymphoma treat
Externí odkaz:
https://doaj.org/article/5faa13572f5842b490fbc2b2496eba87
Autor:
Thomas Gastinne, Julien Lazarovici, Veronique Edeline, Alexandra Traverse-Glehen, Anne Corby, Lysiane Molina, Nawel Belmecheri, Krimo Bouabdallah, Sandy Amorim, Diane Damotte, David Sibon, Rene-Olivier Casasnovas, Vincent Ribrag, Emmanuelle Nicolas-Virelizier, Franck Morschhauser, Alina Berriolo-Riedinger, Thierry Vander Borght, Anne-Claire Gac, Bohrane Slama, Eric Durot, Stéphanie Guidez, Vincent Launay, Pierre Feugier, Kamel Laribi, Marc André
Publikováno v:
Blood. 138:232-232
Background In contrast to the high cure rates in young patients (pts) treated with anthracycline-based chemotherapy, classical Hodgkin lymphoma (cHL) prognosis is poor in elderly pts, and very few data exist for pts considered too frail to receive st
Autor:
Djamel Mokart, Boris Calmels, Nawel Belmecheri, Catherine Faucher, Catalina Montes de Oca, Luca Castagna, Christian Chabannon, Claude Lemarie, Thomas Pagliardini, Samia Harbi, Raynier Devillier, Jean El-Cheikh, Evelyne D'Incan, Cecile Braticevic, Sabine Furst, Valerio Maisano, Reda Bouabdallah, Angela Granata, Didier Blaise, Colombe Saillard, Maud Cecile, Norbert Vey, Faezeh Legrand
Publikováno v:
Blood. 134:4625-4625
Advanced hematologic malignancies in older patients are unmet medical needs due to increased incidence in the aging population and the lack of effective treatment. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents the only pot
Autor:
Claude Lemarie, Thérèse Aurran, Thomas Pagliardini, Boris Calmels, Stefania Bramanti, Faezeh Legrand, Raynier Devillier, Carmelo Carlo-Stella, Jean Marc Schiano de Collela, Nawel Belmecheri, Samia Harbi, Armando Santoro, Luca Castagna, Sabine Furst, Didier Blaise, Valerio Maisano, Angela Granata, Reda Bouabdallah, Christian Chabannon, Diane Coso, Catalina Montes de Oca, Anne-Marie Stoppa
Publikováno v:
Blood. 134:4614-4614
Introduction: allogeneic transplantation (allo-HSCT) is a curative treatment for patients with advanced lymphoma. Haploidentical (haplo-SCT) transplantation extended the accessibility to allo-HSCT, overcoming the issue of donor availability. However,
Autor:
L. Mescam, Thérèse Aurran-Schleinitz, Didier Blaise, Stoppa Am, C. Montes de Oca, B. Slama, Diane Coso, S. Cournier, Nawel Belmecheri, R. Bouabdallah, Vadim Ivanov, J. Bladé, J.-M. Schiano de Collela, C. Zemmour
Publikováno v:
Hematological Oncology. 37:433-433
Autor:
Reda Bouadaballah, Jean El Cheikh, Didier Blaise, Catherine Faucher, Diane Coso, Alberto Vazquez, Alix Helvig, Nawel Belmecheri, Roberto Crocchiolo, Sabine Furst, Luca Castagna, Angela Granata
Publikováno v:
Web of Science
Abstract 1319 Introduction: both B and T cells are implicated in the pathophysiology of graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (AlloSCT). Anti-thymocyte globulin (ATG) administered during conditionin
Autor:
Roberto Crocchiolo, Sabine Furst, Luca Castagna, Jean El Cheikh, Catherine Faucher, Raynier Deviller, Claire Oudin, Alberto Vazquez, Nawel Belmecheri, Angela Granata, Didier Blaise
Publikováno v:
Web of Science
Abstract 3485 Introduction: RIC associating Fludarabine-Busulfan-ATG (FBA) is quite popular as preparative for allogeneic hematopoietic stem cell transplantation (RIC-AlloSCT). However the best association us still a matter of debate. Busulfan is cru
Autor:
Alberto Vazquez, Luca Castagna, Norbert Vey, Sabine Furst, Jean El Cheikh, Raynier Devilliers, Catherine Faucher, Roberto Crocchiolo, Didier Blaise, Evelyne D'Incan, Nawel Belmecheri, Angela Granata
Publikováno v:
Web of Science
Publons
Publons
Abstract 1316 Introduction: reduced-intensity conditioning (RIC) for allogeneic hematopoietic stem cell transplantation (AlloSCT) are usually used in non-fit or elderly patients (pts) as alternative to myeloablative conditoning (MAC). As a consequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a074c343ab35999d7ebf315a362ad38
https://publons.com/wos-op/publon/34315779/
https://publons.com/wos-op/publon/34315779/